Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
- To analyse the concentration catecholamines in thrombocytes of patients with clear cell
renal cell carcinoma and low grade neuroendocrine tumours.
- To compare these concentrations with the concentrations catecholamines in thrombocytes
of healthy controls.
- To analyse the concentration catecholamines in thrombocytes of patients with clear cell
renal cell carcinoma and patients with low grade neuroendocrine tumours with and
without medication.
Observational
Observational Model: Cohort, Time Perspective: Cross-Sectional
Difference in concentrations DA and 5-HT in thrombocytes of patients with clear cell renal cell carcinoma and healthy controls, and patients with low grade neuroendocrine tumours and healthy controls.
one year
No
Sjoukje F. Oosting, MD
Study Chair
University Medical Centre Groningen
The Netherlands: Medical Ethics Review Committee (METC)
230520112
NCT01398306
July 2011
April 2012
Name | Location |
---|